Integra Lifesciences Holdings Corp (IART)
22.99
+0.06
(+0.26%)
USD |
NASDAQ |
Nov 21, 16:00
22.99
0.00 (0.00%)
After-Hours: 20:00
Integra Lifesciences Holdings Profit Margin (Quarterly): -2.81% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.81% |
| June 30, 2024 | -2.97% |
| March 31, 2024 | -0.89% |
| December 31, 2023 | 5.00% |
| September 30, 2023 | 5.10% |
| June 30, 2023 | 1.10% |
| March 31, 2023 | 6.36% |
| December 31, 2022 | 13.30% |
| September 30, 2022 | 12.96% |
| June 30, 2022 | 11.26% |
| March 31, 2022 | 8.74% |
| December 31, 2021 | 11.19% |
| September 30, 2021 | 11.17% |
| June 30, 2021 | 8.99% |
| March 31, 2021 | 12.61% |
| December 31, 2020 | 23.86% |
| September 30, 2020 | 8.73% |
| June 30, 2020 | -0.14% |
| March 31, 2020 | 2.59% |
| December 31, 2019 | 3.88% |
| September 30, 2019 | -7.28% |
| June 30, 2019 | 7.75% |
| March 31, 2019 | 9.11% |
| December 31, 2018 | 6.56% |
| September 30, 2018 | 3.63% |
| Date | Value |
|---|---|
| June 30, 2018 | 3.11% |
| March 31, 2018 | 3.08% |
| December 31, 2017 | 12.03% |
| September 30, 2017 | 1.13% |
| June 30, 2017 | 3.84% |
| March 31, 2017 | 2.47% |
| December 31, 2016 | 11.05% |
| September 30, 2016 | 8.05% |
| June 30, 2016 | 5.12% |
| March 31, 2016 | 5.67% |
| December 31, 2015 | 6.21% |
| September 30, 2015 | -14.08% |
| June 30, 2015 | 2.35% |
| March 31, 2015 | 4.14% |
| December 31, 2014 | 7.84% |
| September 30, 2014 | 4.96% |
| June 30, 2014 | 2.09% |
| March 31, 2014 | 1.03% |
| December 31, 2013 | 16.92% |
| September 30, 2013 | -14.22% |
| June 30, 2013 | 0.74% |
| March 31, 2013 | -3.07% |
| December 31, 2012 | 5.96% |
| September 30, 2012 | 6.29% |
| June 30, 2012 | 4.05% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.97%
Minimum
Jun 2024
23.86%
Maximum
Dec 2020
7.00%
Average
7.55%
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| Haemonetics Corp | 9.79% |
| ResMed Inc | 25.43% |
| Globus Medical Inc | 8.28% |
| Perspective Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.42% |
| Return on Assets | -0.17% |
| Return on Invested Capital | -0.20% |
| Gross Profit Margin (Quarterly) | 52.58% |
| Operating Margin (Quarterly) | -2.14% |
| Return on Net Operating Assets | -0.19% |